Loading

Annals of Sports Medicine and Research

Doping Behaviors and Prevention in Amateur Sport: An Update and New Perspective

Mini Review | Open Access | Volume 2 | Issue 4

  • 1. Teaching and Research Unit in Physical Education and Sport (UER-EPS), University of Teacher Education, State of Vaud (HEP-VD), Switzerland
+ Show More - Show Less
Corresponding Authors
Vanessa Lentillon-Kaestner, Teaching and Research Unit in Physical Education and Sport , University of Teacher Education, State of Vaud, Avenue de Cour 25, CH1014 Lausanne, Switzerland Tel: 41-21-316-36-16;
Abstract

Background: Doping is not limited to elite athletes. To reduce doping in sport, it seems important to influence young athletes in primary prevention.

Purpose: Based on previous research, the purpose of this paper is to give an overview on doping behaviors in amateur sport, actual prevention campaigns, and to propose a new perspective in doping prevention.

Methods: This mini-review is based on articles published in English and French between 1990 and 2014 retrieved from different databases (i.e., PubMed, Science Direct, Francis, Cairn. Info). In addition, some edited books and chapter books, and recent research reports were used to complete this mini-review.

Results: Doping is increasingly important among amateur athletes. To date, traditional doping prevention campaigns are often ineffective. In recent years, a new model of prevention campaigns based on fear, coming from the Anglo-Saxon and Scandinavian countries, has been used notably in France (e.g., prevention campaigns for road safety, tobacco, alcohol, cancer). Fear-based campaigns have scientific support and have shown a relatively small but still solid effect on attitudes, intentions and behaviors.

Conclusion: The fight against doping would benefit from trying fear-based antidoping campaigns.

Keywords

Doping , Prevention , Sport , Fear-based campaigns

Citation

Lentillon-Kaestner V (2015) Doping Behaviors and Prevention in Amateur Sport: An Update and New Perspective. A Pilot Study. Ann Sports Med Res 2(4): 1029.

ABBREVIATIONS

EPPM: Extended Parallel Process Model

INTRODUCTION

Based on previous research, the purpose of this paper is to give an overview of doping behaviors in amateur sport, actual prevention campaigns, and to propose a new perspective in doping prevention. This mini-review is based on articles published in English and French between 1990 and 2014 retrieved from different databases (i.e., PubMed, Science Direct, Francis, Cairn. Info). The following words and combinations of words in English and French have been used on databases: #1 doping, #2 drugs, #3 anabolic steroids, #4 amateur sport, #5 recreational sport, #6 prevention, #7 campaigns, #8 fear, #9 threat, #10 EPPM, #11 self-affirmation, (#1 OR #2 OR #3) AND (#4 OR #5 OR #6 OR #7), (#6 OR #7) and (#8 OR #9 OR #10), (#6 OR #7 OR #8 OR #9 OR #10) AND (#11). In addition, some edited books and chapter books, and recent research reports were used to complete this mini-review. The more significant studies were subjected to narrative synthesis, summarizing the current state of knowledge in relation to doping behaviors and prevention in amateur sport.

Widespread doping behaviors among amateur athletes

Doping is not limited to elite athletes but is widespread in society and is increasingly important among amateur athletes [1-20]. It is difficult to assess the extent of doping in amateur sport, nevertheless it exists [17]. In his review on 44 studies, Laure (1997) estimated the prevalence of doping in children and adolescents participating in sport at 3 to 5 % and in adults participating in amateur sports at 5 to 15 % [7]. In France, 6.7 % of 8-18 year-olds approved doping in sport [21]. Young athletes associated positively sport with drug consumption, at least with energizing drugs [22]. In the study of Turblin et al. (1995), 9 % of students practicing sports outside physical education reported having consumed a substance that they considered as doping [4]. Lentillon-Kaestner and Carstairs (2010) showed that young cyclists (Under-23 category) were tempted by doping [16]. The meta-analysis of Sagoe, Molde and Andreassen (2014) on 187 studies showed a global lifetime prevalence rate of anabolicandrogenic steroid use of 3.3 %.

Doping varies according to various demographic parameters. It increases with age and can start before the age of 15 years [3,4,6,7,19,23-25]. Doping is more widespread among boys than girls [4,21,23-26]; however, the gender gap is decreasing from 10 years old [8]. Doping is more widespread among competitors, and it increases with the level of competition [2,4,6,21,25].

Inefficiency of current anti-doping campaigns

For several years, the fight against doping has mainly focused on the improvement of detection measures (drug tests), leaving aside measures of doping prevention [27-29]. To date, tested anti-doping campaigns are rare, and doping prevention programs lack solid scientific background [27,28,30,31]. Traditional doping prevention campaigns are often ineffective. They describe substances’ side effects, try to persuade users of the ineffectiveness of performance enhancing substances or promote sports ethics [28,32]. The recent meta-analysis of Ntoumakis, Ng, Barkoukis and Backhouse (2014) showed that implemented anti-doping interventions lead to small changes in individuals’ attitudes towards and intention to engage in doping and had no effect on actual doping behaviors [28]. It seems important to build innovative prevention campaigns that are based on solid scientific theory [9,27,30].

The fear-based campaigns

In recent years, a new model of prevention campaign based on fear and coming from the Anglo-Saxon and Scandinavian countries has been used notably in France (e.g., road safety, tobacco, alcohol, cancer prevention campaigns) [33]. Fear is conceptualized as a negative emotional reaction to a perceived threat. The purpose of the fear model is to show the consequences of an undesirable event (e.g., illness, accident) or to give more or less directly a glimpse of the following unhappiness aiming to bring an attitude change. The fear motivates actions to reduce negative emotion [34]. In contrast to current doping prevention campaigns, fear-based campaigns have scientific support [35- 45]. Psychologists and researchers in marketing have tried to understand why a prevention campaign based on phobic emotion resulted sometimes in success (action) and sometimes in failure (defensive reactions). Various theories have been developed. The latest and most advanced theory about fear appeals from a theoretical and empirical point of view [33,40] is the Extended Parallel Process Model (EPPM) of Witte (1992, 1998) [36,46]. In this model, individuals first assess the threat contained in the message. Perceived threat is a cognitive construct with two dimensions: perceived severity of the threat and one’s perceived susceptibility to the threat [47]. In accordance with other metaanalyses, the meta-analysis of Witte and Allen (2000) suggested that the higher the fear level, the higher is the persuasive impact of the message [40]. If the threat is perceived as irrelevant or insignificant, the person is no longer motivated to process the message and simply ignores the fear. In contrast, when a threat is described as significant and relevant, people are frightened. The more people believe themselves vulnerable to a serious threat, the more they are motivated to start the second evaluation of the recommendations’ effectiveness. The fear motivates the change in attitudes, intentions and behaviors, especially fear accompanied with highly effective messages. Perceived effectiveness comprises two dimensions: perceived response effectiveness (beliefs of how effective a response is in averting a threat) and perceived self-effectiveness (beliefs about one’s ability to carry out the recommended response) [47]. Effective messages generating a strong fear encourage behavior change (i.e., danger control), while less effective messages generating a strong fear lead to defensive reactions (i.e., fear control) [40,47,48]. According to Witte (1992), fear-based health campaigns are far more useful to promote prevention behaviors than to modify existing behaviors [46]. Witte and Allen (2000) concluded, from their meta-analysis on 98 studies on fear-based campaigns (e.g., sexuality, alcohol, road safety, tobacco), that fear would have a relatively small but constant effect on attitudes, intentions and behaviors [40]. They also offered a series of recommendations for the implementation of prevention measures [40]. In addition, psychology studies on persuasion showed that a simple message was more persuasive in video than in written or audio forms [49,50].

The theory of self-affirmation appears as a way to increase the effectiveness of prevention campaigns through a re-evaluation of the self-image, which reduces the defensive reactions and increases the acceptance of prevention recommendations [51]. The manipulation of self-affirmation may be achieved in different ways (e.g., values to rank in importance order, to write an essay on their most important value, to describe a very important thing in their lives) [52]. Research has shown that to secure the self through self-affirmation manipulation reduced defensive reactions to threatening health information [51] and positively influenced healthier behaviors [53,54]. Through the self-affirmation process, prevention campaigns do not threaten the self-image of the person, but only the behavior is threatened [51,52].

New perspectives in doping prevention

Adolescence is a high-risk period for the development of doping behaviors [55]. Even if performance enhancing drugs have adverse effects on health [12,29,56-58], young athletes are tempted by doping and are not afraid of health side effects [59,60]. Young athletes are priority target as their doping attitudes are in formation and primary prevention seems to be a good solution to avoid the appearance of doping behaviors.

To date, no previous study has evaluated the effects of fearbased anti-doping campaigns and the fight against doping would benefit from trying a fear-based doping prevention video for two main reasons. Firstly, although very significant progress has been made in detection measures in recent years in the fight against doping, prevention campaigns remain limited. Actual implemented doping prevention measures are ineffective and without scientific support. Secondly, doping prevention lacks standardized, effective and easy tools to use in both the sport and the academic domains. A doping prevention video could be used during sport events and competitions. Doping prevention is also a topic addressed in sport courses (i.e., additional sport option, sports study) in high schools and in universities. A fear-based antidoping video would be directly useful for all stakeholders (e.g., teachers, coaches, sport and doping prevention organizations) who wish to address this issue with athletes and students. It will prevent the development of prevention campaigns that may have opposite effects than expected. To indicate the main effects of doping substances (which is common in prevention campaigns) has counterproductive effects on athletes by even increasing their desire to test these substances. Doping is not an easy issue to address. The fear-based doping prevention video would encourage a debate among young people and should reduce the athletes’ intentions to use doping.

REFERENCES

1. Anderson WA, Albrecht RR, McKeag DB, Hough DO, McGrew CA. A national survey of alcohol and drugs use by college athletes. Physician and Sportsmedicine. 1991; 19: 91-104.

2. Skowno J. Drug survey among first-team schoolboy rugby players. S Afr Med J. 1992; 82: 204.

3. Radakovich J, Broderick P, Pickell G. Rate of anabolic-androgenic steroid use among students in junior high school. J Am Board Fam Pract. 1993; 6: 341-345.

4. Turblin P, Grosclaude P, Navarro F, Rivière D, Garrigues M. Enquête épidémiologique sur le dopage en milieu scolaire dans la région MidiPyrénées. Science & Sports. 1995;10: 87-94.

5. MacAuley D. Drugs in sport. BMJ. 1996; 313: 211-215.

6. Melia P, Pipe A, Greenberg L. The use of anabolic-androgenic steroids by Canadian students. Clin J Sport Med. 1996; 6: 9-14.

7. Laure P. Epidemiologic approach of doping in sport. A review. J Sports Med Phys Fitness. 1997; 37: 218-224.

8. Yesalis CE, Barsukiewicz CK, Kopstein AN, Bahrke MS. Trends in anabolic-androgenic steroid use among adolescents. Arch Pediatr Adolesc Med. 1997; 151: 1197-1206.

9. Yesalis CE, Bahrke MS. Doping among adolescent athletes. Baillieres Best Pract Res Clin Endocrinol Metab. 2000; 14: 25-35.

10. Pillard F, Grosclaude P, Navarro F, Godeau E, Rivière D. Pratique sportive et conduite dopante d’un échantillon représentatif des élèves de Midi-Pyrénées. Science & Sports 2002; 17: 8-16.

11. Laure P, Binsinger C. Adolescent athletes and the demand and supply of drugs to improve their performance. J Sports Sci Med. 2005; 4: 272- 277.

12. Calfee R, Fadale P. Popular ergogenic drugs and supplements in young athletes. Pediatrics. 2006; 117: e577-589.

13. Laure P, Binsinger C. Doping prevalence among preadolescent athletes: a 4-year follow-up. Br J Sports Med. 2007; 41: 660-663.

14. Nandrino JL, Escande J-D, Faure S, Doba K, Vandeweeghe E. Profil psychologique et comportemental de vulnérabilité à la dépendance à l’exercice et au risque de pratiques dopantes chez les sportifs amateurs: l’exemple des semi-marathoniens. Annales MédicoPsychologiques. 2008; 166: 772-778.

15. Sjöqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet. 2008; 371: 1872-1882.

16. Lentillon-Kaestner V, Carstairs C. Doping use among young elite cyclists: a qualitative psychosociological approach. Scand J Med Sci Sports. 2010; 20: 336-345.

17. Lentillon-Kaestner V, Ohl F. Can we measure accurately the prevalence of doping? Scand J Med Sci Sports. 2011; 21: e132-142.

18. Zelli A, Mallia L, Lucidi F. The contribution of interpersonal appraisals to a social-cognitive analysis of adolescents’ doping use. Psychology of Sport and Exercise. 2010; 11: 304-311.

19. Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014; 24: 383-398.

20. Barkoukis V, Lazuras L, Harris PR. The effects of self affirmation manipulation on decision making about doping use in elite athletes. Psychology of Sport and Exercise. 2015; 16: 1-7.

21. Laure P. Dopage et société. Paris: Ellipses; 2000.

22. CNRS. Dopage et pratiques sportives. Paris: Expertise collective CNRS; 1998.

23. Dunn MO, Thomas J. A risk profile of elite Australian athletes who use illicit drugs. Addict Behav. 2012; 37: 144-147.

24. Scott DM, Wagner JC, Barlow TW. Anabolic steroid use among adolescents in Nebraska schools. Am J Health Syst Pharm. 1996; 53: 2068-2072.

25. Pillard F, Grosclaude P, Navarro F, Godeau E, Rivière D. Enquête épidémiologique sur le dopage sportif en milieu scolaire dans la région midi-pyrénées en 1999. Résultats préliminaires. Bulletin Epidémiologique Hebdomadaire (BEH). 2000; 42: 185-186.

26. Mignon P. Le dopage: état des lieux sociologiques. Paris: Université Paris 5 René Descartes, 2002.

27. Backhouse SH, Patterson, L, McKenna, J. Achieving the Olympic ideal: preventing doping in sport. Performance Enhancement & Health. 2012; 1: 83-85.

28. Ntoumanis N, Ng JY, Barkoukis V, Backhouse S. Personal and psychosocial predictors of doping use in physical activity settings: a meta-analysis. Sports Med. 2014; 44: 1603-1624.

29. Overbye M, Knudsen, M.L, Pfister, G. To dope or not to dope: Elite athletes’ perceptions of doping deterrents and incentives. Performance Enhancement & Health. 2013; 2: 119-134.

30. Johnson MB. A systemic social cognitive perspective on doping. Psychology of sport and exercise. 2012; 13: 317-323.

31. Moston S, Engelberg, T, Skinner, J. Self fulfilling prophecy and the future of doping. Psychology of Sport and Exercise. 2015; 16: 201-207.

32. Laure P, Lecerf T. Prévention du dopage chez les adolescents: comparaison d’une démarche éducative et d’une démarche informative. Science & Sports. 2002; 17: 198-201.

33. Gallopel K, Petr C. Utilisation de la peur dans les campagnes de prévention : résultats et discussions autour des comportements tabagiques de jeunes français. Convegno Le Tendenze del marketing in Europa; Venise; 2000.

34. Gallopel K. L’utilisation de la peur dans un contexte de marketing social: état de l’art, limites et voies de recherche. Recherche et Application en Marketing. 2006; 21: 41-60.

35. Witte K. Fear control and danger control: a test of the extended parallel process model (EPPM). Communication Monographs. 1994; 61: 113-134.

36. Witte K, Berkowitz JM, Cameron KA, McKeon JK. Preventing the spread of genital warts: using fear appeals to promote self-protective behaviors. Health Educ Behav. 1998; 25: 571-585.

37. Moscato S, Black DR, Blue CL, Mattson M, Galer-Unti RA, Coster DC. Evaluating a fear appeal message to reduce alcohol use among “Greeks”. Am J Health Behav. 2001; 25: 481-491.

38. Tay R, Watson B. Changing drivers intentions and behaviours using fear-based driver fatigue advertisements. Health Mark Q. 2002; 19: 55-68.

39. Smalec JL, Klingle RS. Bulimia interventions via interpersonal influence: the role of threat and efficacy in persuading bulimics to seek help. J Behav Med. 2000; 23: 37-57.

40. Witte K, Allen M. A meta-analysis of fear appeals: implications for effective public health campaigns. Health Educ Behav. 2000; 27: 591- 615.

41. McKay DL, Berkowitz JM, Blumberg JB, Goldberg JP. Communicating cardiovascular disease risk due to elevated homocysteine levels: Using the EPPM to develop print materials. Health Education & Behavior. 2004; 31: 355-371.

42. Smith SW, Rosenman KD, Kotowski MR, Glazer E, McFeters C, Keesecker NM, et al. Using the EPPM to create and evaluate the effectiveness of brochures to increase the use of hearing protection in farmers and landscape workers. Journal of Applied Communication Research. 2008; 36: 200-218.

43. Wong NC, Cappella JN. Antismoking Threat and Efficacy Appeals: Effects on Smoking Cessation Intentions for Smokers with Low and High Readiness to Quit. J Appl Commun Res. 2009; 37: 1-20.

44. Cho H, Witte K. Managing fear in public health campaigns: a theorybased formative evaluation process. Health Promot Pract. 2005; 6: 482-490.

45. Morrison K. Motivating women and men to take protective action against rape: examining direct and indirect persuasive fear appeals. Health Commun. 2005; 18: 237-256.

46. Witte K. Putting the fear back into fear appeals: the Extended Parallel Process Model. Communication Monographs. 1992; 59: 329-349.

47. Popova L. The extended parallel process model: illuminating the gaps in research. Health Educ Behav. 2012; 39: 455-473.

48. Ruiter R, Verplanken B, De Cremer D, Kok G. Danger and fear control in response to fear appeals: the role of need for cognition. Basic and Applied Social Psychology. 2004; 26: 13-24.

49. Girandola F. Peur et persuasion: présentations des recherches (1953- 1998) et d’une nouvelle lecture. L’Année Psychologique. 2000; 100: 333-376.

50. Girandola F. Psychologie de la persuasion et de l’engagement: Presses Universitaires de Franche-Comté; 2003.

51. Sherman DAK, Nelson LD, Steele CM. Do messages about health risks threaten the self? Increasing the acceptance of threatening health messages via self-affirmation. Personality and Social Psychology Bulletin. 2000; 26: 1046-1058.

52. McQueen A, Klein WMP. Experimental manipulations of selfaffirmation: a systematic review. Self-identity. 2006; 5: 289-354.

53. Harris PR. Self-affirmation and the self-regulation of health behavior change. Self and Identity. 2011; 10: 304-314.

54. Harris PR, Epton T. The impact of self-affirmation on health cognition, health behavior and other health-related responses: a narrative review. Social and Personality Compass. 2009; 3: 962-978.

55. Schirlin O, Rey G, Jouvent R, Dubal S, Komano O, Perez-Diaz F, et al. Attentional bias for doping words and its relation with physical selfesteem in young adolescents. Psychology of Sport and Exercise. 2009; 10: 615-620.

56. Maravelias C, Dona A, Stefanidou M, Spiliopoulou C. Adverse effects of anabolic steroids in athletes. A constant threat. Toxicol Lett. 2005; 158: 167-175.

57. Grossi O, Généreau T. Glucocorticoids and infections, doping, surgery, sexuality. Rev Med Interne. 2013; 34: 269-278.

58. Dine G, Van Lierde, F, Rehn, Y, Gillier, N. Problèmes associés à l’usage de l’érythropoïétine en milieu sportif. Revues Générales et Analyses Prospectives. 2001: 235-243.

59. Irving LM, Wall M, Neumark-Sztainer D, Story M. Steroid use among adolescents: findings from Project EAT. J Adolesc Health. 2002; 30: 243-252.

60. Lentillon-Kaestner V, Hagger MS, Hardcastle S. Health and doping in elite-level cycling. Scand J Med Sci Sports. 2012; 22: 596-606.

Lentillon-Kaestner V (2015) Doping Behaviors and Prevention in Amateur Sport: An Update and New Perspective. A Pilot Study. Ann Sports Med Res 2(4): 1029.

Received : 23 Mar 2015
Accepted : 30 Apr 2015
Published : 04 May 2015
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X